0001209191-23-021443.txt : 20230328 0001209191-23-021443.hdr.sgml : 20230328 20230328190904 ACCESSION NUMBER: 0001209191-23-021443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230324 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harris Todd CENTRAL INDEX KEY: 0001711463 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 23771313 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD STREET 2: SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-24 0 0001863127 Tyra Biosciences, Inc. TYRA 0001711463 Harris Todd C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-03-24 4 M 0 170 2.25 A 1701446 D Common Stock 2023-03-24 4 S 0 170 16.00 D 1701276 D Common Stock 2023-03-27 4 M 0 2963 2.25 A 1704239 D Common Stock 2023-03-27 4 S 0 2963 16.00 D 1701276 D Common Stock 2023-03-28 4 M 0 2779 2.25 A 1704055 D Common Stock 2023-03-28 4 S 0 2779 16.00 D 1701276 D Stock Option (Right to Buy) 2.25 2023-03-24 4 M 0 170 0.00 D 2031-03-09 Common Stock 170 409606 D Stock Option (Right to Buy) 2.25 2023-03-27 4 M 0 2963 0.00 D 2031-03-09 Common Stock 2963 406643 D Stock Option (Right to Buy) 2.25 2023-03-28 4 M 0 2779 0.00 D 2031-03-09 Common Stock 2779 403864 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022. 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. /s/ Ali D. Fawaz, Attorney-in-Fact 2023-03-28